Richard Hoppe

Publications

• Revisiting low-dose total skin electron beam therapy in mycosis fungoides. Harrison C, Young J, Navi D, Riaz N, Lingala B, Kim Y, Hoppe R. Int J Radiat Oncol Biol Phys. 2011; 81 (4): e651-7
• Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience. Advani RH, Hoppe RT, Maeda LS, Baer DM, Mason J, Rosenberg SA, Horning SJ. Int J Radiat Oncol Biol Phys. 2011; 81 (5): 1374-9
• In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study. Brody JD, Ai WZ, Czerwinski DK, Torchia JA, Levy M, Advani RH, Kim YH, Hoppe RT, Knox SJ, Shin LK, Wapnir I, Tibshirani RJ, Levy R. J Clin Oncol. 2010; 28 (28): 4324-32
• Cutaneous peripheral T-cell lymphoma associated with a proliferation of B cells. Mattoch IW, Fulton R, Kim Y, Hoppe R, Warnke RA, Sundram UN. Am J Clin Pathol. 2009; 131 (6): 810-9
• Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus antigens in patients with Epstein-Barr virus-negative Hodgkin's disease. Kohrt H, Johannsen A, Hoppe R, Horning SJ, Rosenberg SA, Advani R, Lee PP. Oncol Res. 2009; 18 (5-6): 287-92
• Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin. Weinberg OK, Ma L, Seo K, Beck AH, Pai RK, Morales A, Kim Y, Sundram U, Tan D, Horning SJ, Hoppe RT, Natkunam Y, Arber DA. Am J Surg Pathol. 2009; 33 (4): 591-8
• Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome. Woo DK, Jones CR, Vanoli-Storz MN, Kohler S, Reddy S, Advani R, Hoppe RT, Kim YH. Arch Dermatol. 2009; 145 (6): 667-74
• TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Kohrt HE, Turnbull BB, Heydari K, Shizuru JA, Laport GG, Miklos DB, Johnston LJ, Arai S, Weng WK, Hoppe RT, Lavori PW, Blume KG, Negrin RS, Strober S, Lowsky R. Blood. 2009; 114 (5): 1099-109
• Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease. Lee J, Viakhireva N, Cesca C, Lee P, Kohler S, Hoppe RT, Kim YH. J Am Acad Dermatol. 2008; 59 (4): 706-12
• Hodgkin disease/lymphoma. Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K, Dabaja B, Djulbegovic B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hudson MM, Kaminski MS, Love G, Maloney DG, Mansur D, Mauch PM, Moore JO, Schilder RJ, Weiss LM, Winter JN, Yahalom J, Zelenetz AD. J Natl Compr Canc Netw. 2008; 6 (6): 594-622
• Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab. Morales AV, Advani R, Horwitz SM, Riaz N, Reddy S, Hoppe RT, Kim YH. J Am Acad Dermatol. 2008; 59 (6): 953-7
• Tolerance and chimerism after renal and hematopoietic-cell transplantation. Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, Hoppe RT, Lowsky R, Engleman EG, Strober S. N Engl J Med. 2008; 358 (4): 362-8
• Hodgkin's lymphoma: the role of radiation in the modern combined strategies of treatment. Hoppe RT, Hematol Oncol Clin North Am. 2007; 21 (5): 915-27
• Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. Advani R, Maeda L, Lavori P, Quon A, Hoppe R, Breslin S, Rosenberg SA, Horning SJ. J Clin Oncol. 2007; 25 (25): 3902-7
• Revised response criteria for malignant lymphoma. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V. J Clin Oncol. 2007; 25 (5): 579-86
• Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, Tate DJ, Horning SJ, Hoppe RT, Hancock SL. J Clin Oncol. 2007; 25 (1): 43-9
• Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH. Arch Dermatol. 2007; 143 (1): 45-50
• TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A, Dummer R, Hoppe RT. Blood. 2007; 110 (2): 479-84
• Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Tsai EY, Taur A, Espinosa L, Quon A, Johnson D, Dick S, Chow S, Advani R, Warnke R, Kohler S, Hoppe RT, Kim YH. Arch Dermatol. 2006; 142 (5): 577-84
• A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies. Flores MG, Holm B, Larson MJ, Lau MK, Si MS, Lowsky R, Rousvoal G, Grumet FC, Strober S, Hoppe R, Reitz BA, Borie DC. J Surg Res. 2005; 124 (2): 280-8
• Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study. Sundram U, Kim Y, Mraz-Gernhard S, Hoppe R, Natkunam Y, Kohler S. J Cutan Pathol. 2005; 32 (3): 227-34
• Protective conditioning for acute graft-versus-host disease. Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, Shizuru JA, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Hoppe RT, Bloch DA, Blume KG, Negrin RS, Strober S. N Engl J Med. 2005; 353 (13): 1321-31
• Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients. Beynet DP, Wee SA, Horwitz SS, Kohler S, Horning S, Hoppe R, Kim YH. Arch Dermatol. 2004; 140 (9): 1140-6
• Extranodal nonorbital indolent lymphomas of the head and neck: relationship between tumor control and radiotherapy. MacDermed D, Thurber L, George TI, Hoppe RT, Le QT. Int J Radiat Oncol Biol Phys. 2004; 59 (3): 788-95
• Short tandem repeat analysis to monitor chimerism in macaca fascicularis. Lau M, Vayntrub T, Grumet FC, Lowsky R, Strober S, Hoppe R, Larson M, Holm B, Reitz B, Borie D. Am J Transplant. 2004; 4 (9): 1543-8
• CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. Liu HL, Hoppe RT, Kohler S, Harvell JD, Reddy S, Kim YH. J Am Acad Dermatol. 2003; 49 (6): 1049-58
• Gene expression profiles of cutaneous B cell lymphoma. Storz MN, van de Rijn M, Kim YH, Mraz-Gernhard S, Hoppe RT, Kohler S. J Invest Dermatol. 2003; 120 (5): 865-70
• Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Arch Dermatol. 2003; 139 (7): 857-66
• Mycosis fungoides: radiation therapy. Hoppe RT, Dermatol Ther. 2003; 16 (4): 347-54
• Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. Ekstrand BC, Lucas JB, Horwitz SM, Fan Z, Breslin S, Hoppe RT, Natkunam Y, Bartlett NL, Horning SJ. Blood. 2003; 101 (11): 4285-9
• Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience. Kim YH, Martinez G, Varghese A, Hoppe RT. Arch Dermatol. 2003; 139 (2): 165-73
• Hodgkin's disease: a model for interdisciplinary cancer management: 2002 Janeway lecture. Hoppe RT, Cancer J. 2002 Nov-Dec; 8 (6): 425-31
• Long-term follow-up after total lymphoid irradiation in pediatric heart transplant recipients. Chin C, Hunt S, Robbins R, Hoppe R, Reitz B, Bernstein D. J Heart Lung Transplant. 2002; 21 (6): 667-73
• Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Millan MT, Shizuru JA, Hoffmann P, Dejbakhsh-Jones S, Scandling JD, Grumet FC, Tan JC, Salvatierra O, Hoppe RT, Strober S. Transplantation. 2002; 73 (9): 1386-91
• Primary radiotherapy for localized orbital MALT lymphoma. Le QT, Eulau SM, George TI, Hildebrand R, Warnke RA, Donaldson SS, Hoppe RT. Int J Radiat Oncol Biol Phys. 2002; 52 (3): 657-63
• Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial. Horning SJ, Hoppe RT, Breslin S, Bartlett NL, Brown BW, Rosenberg SA. J Clin Oncol. 2002; 20 (3): 630-7
• NCCN: Non-Hodgkin's lymphoma. Zelenetz AD, Hoppe RT. Cancer Control. 2001 Nov-Dec; 8 (6 Suppl 2): 102-13
• Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides. de Coninck EC, Kim YH, Varghese A, Hoppe RT. J Clin Oncol. 2001; 19 (3): 779-84
• High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. Horning SJ, Negrin RS, Hoppe RT, Rosenberg SA, Chao NJ, Long GD, Brown BW, Blume KG. Blood. 2001; 97 (2): 404-9
• High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience. Cao TM, Horning S, Negrin RS, Hu WW, Johnston LJ, Taylor TL, Shizuru JA, Hoppe RT, Brown BW, Blume KG, Stockerl-Goldstein KE. Biol Blood Marrow Transplant. 2001; 7 (5): 294-301
• Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University. Murtha AD, Rupnow BA, Hansosn J, Knox SJ, Hoppe R. Int J Radiat Oncol Biol Phys. 2001; 49 (1): 3-15
• Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. Mraz-Gernhard S, Natkunam Y, Hoppe RT, LeBoit P, Kohler S, Kim YH. J Clin Oncol. 2001; 19 (8): 2179-88
• Assessment of the stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group pilot study E1492. Horning SJ, Williams J, Bartlett NL, Bennett JM, Hoppe RT, Neuberg D, Cassileth P. J Clin Oncol. 2000; 18 (5): 972-80
• Management of breast cancer after Hodgkin's disease. Wolden SL, Hancock SL, Carlson RW, Goffinet DR, Jeffrey SS, Hoppe RT. J Clin Oncol. 2000; 18 (4): 765-72
• Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma. Johnston LJ, Stockerl-Goldstein KE, Hu WW, Negrin RS, Hoppe RT, Blume KG, Horning SJ. Biol Blood Marrow Transplant. 2000; 6 (5A): 555-62
• The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects. Donaldson SS, Hancock SL, Hoppe RT. Cancer J Sci Am. 1999 Nov-Dec; 5 (6): 325-33
• Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Kim YH, Chow S, Varghese A, Hoppe RT. Arch Dermatol. 1999; 135 (1): 26-32
• Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides. Chui CT, Hoppe RT, Kohler S, Kim YH. J Am Acad Dermatol. 1999; 41 (2 Pt 1): 271-4
• Mycosis fungoides and the Sézary syndrome. Kim YH, Hoppe RT. Semin Oncol. 1999; 26 (3): 276-89
• Results of the 1988-1989 Patterns of Care Study process survey for Hodgkin's disease. Smitt MC, Stouffer N, Owen JB, Hoppe RT, Hanks GE. Int J Radiat Oncol Biol Phys. 1999; 43 (2): 335-9
• Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides. Chinn DM, Chow S, Kim YH, Hoppe RT. Int J Radiat Oncol Biol Phys. 1999; 43 (5): 951-8
• What is the significance of nasal involvement in nasopharyngeal carcinoma? Lin ZX, Li DR, Chen ZJ, Zheng MZ, Shi YY, Lin BH, Kapp DS, Hoppe RT. Int J Radiat Oncol Biol Phys. 1999; 45 (4): 907-14
• Mycosis fungoides in young patients: clinical characteristics and outcome. Crowley JJ, Nikko A, Varghese A, Hoppe RT, Kim YH. J Am Acad Dermatol. 1998; 38 (5 Pt 1): 696-701
• Radiation therapy as a component of high-dose salvage strategies in Hodgkin's disease. Hoppe RT, Ann Oncol. 1998: 9 Suppl 5 S87-90
• Role of histology in providing prognostic information in mycosis fungoides. Smoller BR, Detwiler SP, Kohler S, Hoppe RT, Kim YH. J Cutan Pathol. 1998; 25 (6): 311-5
• Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Hausdorff J, Davis E, Long G, Hoppe R, van der Pas M, Lassman C, Kamel O, Jacobs C. Cancer J Sci Am. 1997 Sep-Oct; 3 (5): 303-11
• Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Yuen AR, Rosenberg SA, Hoppe RT, Halpern JD, Horning SJ. Blood. 1997; 89 (3): 814-22
• Detection of relapse in early-stage Hodgkin's disease: role of routine follow-up studies. Torrey MJ, Poen JC, Hoppe RT. J Clin Oncol. 1997; 15 (3): 1123-30
• Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG. Biol Blood Marrow Transplant. 1997; 3 (6): 324-30
• Gastrointestinal cancer after treatment of Hodgkin's disease. Birdwell SH, Hancock SL, Varghese A, Cox RS, Hoppe RT. Int J Radiat Oncol Biol Phys. 1997; 37 (1): 67-73
• High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices. Horning SJ, Chao NJ, Negrin RS, Hoppe RT, Long GD, Hu WW, Wong RM, Brown BW, Blume KG. Blood. 1997; 89 (3): 801-13
• Hodgkin's disease: complications of therapy and excess mortality. Hoppe RT, Ann Oncol. 1997: 8 Suppl 1 115-8
• Long-term depletion of naive T cells in patients treated for Hodgkin's disease. Watanabe N, De Rosa SC, Cmelak A, Hoppe R, Herzenberg LA, Roederer M. Blood. 1997; 90 (9): 3662-72
• Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection. Wolden SL, Tate DJ, Hunt SA, Strober S, Hoppe RT. Int J Radiat Oncol Biol Phys. 1997; 39 (5): 953-60
• Over 20 Years of Progress in Radiation Oncology: Hodgkin's Disease. Smitt MC, Buzydlowski J, Hoppe RT. Semin Radiat Oncol. 1997; 7 (2): 127-134
• Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. Horning SJ, Hoppe RT, Mason J, Brown BW, Hancock SL, Baer D, Rosenberg SA. J Clin Oncol. 1997; 15 (5): 1736-44
• Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update. Horning SJ, Rosenberg SA, Hoppe RT. Ann Oncol. 1996: 7 Suppl 4 105-8
• Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT. Arch Dermatol. 1996; 132 (11): 1309-13
• High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival. Poen JC, Hoppe RT, Horning SJ. Int J Radiat Oncol Biol Phys. 1996; 36 (1): 3-12
• Hodgkin's disease--the role of radiation therapy in advanced disease. Hoppe RT, Ann Oncol. 1996: 7 Suppl 4 99-103
• Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma. Stockerl-Goldstein KE, Horning SJ, Negrin RS, Chao NJ, Hu WW, Long GD, Hoppe RT, Amylon MD, Brown BW, Wong RM, Blume KG. Biol Blood Marrow Transplant. 1996; 2 (2): 76-85
• Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. Mac Manus MP, Hoppe RT. J Clin Oncol. 1996; 14 (4): 1282-90
• Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. Hancock SL, Hoppe RT. Semin Radiat Oncol. 1996; 6 (3): 225-242
• Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody. Knox S, Hoppe RT, Maloney D, Gibbs I, Fowler S, Marquez C, Cornbleet PJ, Levy R. Blood. 1996; 87 (3): 893-9
• Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report. Bartlett NL, Rosenberg SA, Hoppe RT, Hancock SL, Horning SJ. J Clin Oncol. 1995; 13 (5): 1080-8
• CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. Hoppe RT, Medeiros LJ, Warnke RA, Wood GS. J Am Acad Dermatol. 1995; 32 (3): 448-53
• Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides. Becker M, Hoppe RT, Knox SJ. Int J Radiat Oncol Biol Phys. 1995; 32 (5): 1445-9
• Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease--an analysis of risk, management, and outcome. Tate DJ, Hoppe RT. Int J Radiat Oncol Biol Phys. 1995; 32 (4): 1239-44
• Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome. Kim YH, Bishop K, Varghese A, Hoppe RT. Arch Dermatol. 1995; 131 (9): 1003-8
• Effect of filgrastim (G-CSF) in Hodgkin's disease patients treated with radiation therapy. Knox SJ, Fowler S, Marquez C, Hoppe RT. Int J Radiat Oncol Biol Phys. 1994; 28 (2): 445-50
• Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study. Horning SJ, Adhikari A, Rizk N, Hoppe RT, Olshen RA. J Clin Oncol. 1994; 12 (2): 297-305
• Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. Horning SJ, Negrin RS, Chao JC, Long GD, Hoppe RT, Blume KG. J Clin Oncol. 1994; 12 (12): 2552-8
• Treatment of early-stage gastric lymphoma. Ben-Yosef R, Hoppe RT. J Surg Oncol. 1994; 57 (2): 78-86
• Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatment. Abel EA, Wood GS, Hoppe RT. CA Cancer J Clin. 1993 Mar-Apr; 43 (2): 93-115
• Breast cancer after treatment of Hodgkin's disease. Hancock SL, Tucker MA, Hoppe RT. J Natl Cancer Inst. 1993; 85 (1): 25-31
• Cardiac disease following treatment of Hodgkin's disease in children and adolescents. Hancock SL, Donaldson SS, Hoppe RT. J Clin Oncol. 1993; 11 (7): 1208-15
• Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. Hancock SL, Tucker MA, Hoppe RT. JAMA. 1993; 270 (16): 1949-55
• Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy. Behar RA, Horning SJ, Hoppe RT. Int J Radiat Oncol Biol Phys. 1993; 25 (5): 771-6
• MR imaging to detect chest wall and pleural involvement in patients with lymphoma: effect on radiation therapy planning. Carlsen SE, Bergin CJ, Hoppe RT. AJR Am J Roentgenol. 1993; 160 (6): 1191-5
• Combined-modality therapy for the treatment of Hodgkin's disease. Hoppe RT, Front Radiat Ther Oncol. 1992: 26 172-80
• Secondary leukemia and myelodysplastic syndrome after treatment for Hodgkin's disease. Hoppe RT, Leukemia. 1992: 6 Suppl 4 155-7
• The Stanford experience with combined procarbazine, Alkeran and vinblastine (PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's disease. Horning SJ, Ang PT, Hoppe RT, Rosenberg SA. Ann Oncol. 1992; 3 (9): 747-54
• The management of Hodgkin's disease in relapse after primary radiation therapy. Hoppe RT, Eur J Cancer. 1992; 28A (11): 1920-2
• Total lymphoid irradiation for treatment of intractable cardiac allograft rejection. Hunt SA, Strober S, Hoppe RT, Stinson EB. J Heart Lung Transplant. 1991 Mar-Apr; 10 (2): 211-6
• Metastatic carcinoma in lymph nodes simulating "syncytial variant" of nodular sclerosing Hodgkin's disease. Bacchi CE, Dorfman RF, Hoppe RT, Chan JK, Warnke RA. Am J Clin Pathol. 1991; 96 (5): 589-93
• Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides. Knox SJ, Levy R, Hodgkinson S, Bell R, Brown S, Wood GS, Hoppe R, Abel EA, Steinman L, Berger RG. Blood. 1991; 77 (1): 20-30
• The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary data. Horning SJ, Chao NJ, Negrin RS, Hoppe RT, Kwak LW, Long GD, Stallbaum B, O'Connor P, Blume KG. Ann Oncol. 1991: 2 Suppl 1 47-50
• The management of mycosis fungoides at Stanford--standard and innovative treatment programmes. Hoppe RT, Leukemia. 1991: 5 Suppl 1 46-8
• Total skin electron beam therapy in the management of mycosis fungoides. Hoppe RT, Front Radiat Ther Oncol. 1991: 25 80-9; discussion 132-3
• Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment. Hoppe RT, Wood GS, Abel EA. Curr Probl Cancer. 1990 Nov-Dec; 14 (6): 293-371
• Bone marrow transplantation for hematologic malignancies: the Stanford experience. Chao NJ, Amylon MD, Long GD, Negrin RS, Hoppe RT, Horning SJ, Blume KG. Clin Transpl. 1990: 157-63
• Discordant expression of antigens between intraepidermal and intradermal T cells in mycosis fungoides. Michie SA, Abel EA, Hoppe RT, Warnke RA, Wood GS. Am J Pathol. 1990; 137 (6): 1447-51
• Leu-8/CD7 antigen expression by CD3+ T cells: comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values. Wood GS, Hong SR, Sasaki DT, Abel EA, Hoppe RT, Warnke RA, Morhenn VB. J Am Acad Dermatol. 1990; 22 (4): 602-7
• Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease. Roach M, Brophy N, Cox R, Varghese A, Hoppe RT. J Clin Oncol. 1990; 8 (4): 623-9
• Radiation therapy in the management of Hodgkin's disease. Hoppe RT, Semin Oncol. 1990; 17 (6): 704-15
• Radiation therapy in the management of bulky mediastinal Hodgkin's disease. Behar RA, Hoppe RT. Cancer. 1990; 66 (1): 75-9
• Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. Strober S, Dhillon M, Schubert M, Holm B, Engleman E, Benike C, Hoppe R, Sibley R, Myburgh JA, Collins G. N Engl J Med. 1989; 321 (1): 28-33
• Characterization of splenic structure in Hodgkin disease by using narrow-band filtration of backscattered ultrasound. Friedman PA, Sommer FG, Chen HS, Rachlin DJ, Hoppe R. AJR Am J Roentgenol. 1989; 152 (6): 1197-203
• Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia. Wood GS, Ngan BY, Tung R, Hoffman TE, Abel EA, Hoppe RT, Warnke RA, Cleary ML, Sklar J. Am J Pathol. 1989; 135 (1): 13-9
• Current Stanford clinical trials for Hodgkin's disease. Hoppe RT, Horning SJ, Hancock SL, Rosenberg SA. Recent Results Cancer Res. 1989: 117 182-90
• Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma. Medeiros LJ, Picker LJ, Abel EA, Hu CH, Hoppe RT, Warnke RA, Wood GS. J Am Acad Dermatol. 1989; 21 (5 Pt 1): 929-42
• Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sezary syndrome. Weiss LM, Wood GS, Hu E, Abel EA, Hoppe RT, Sklar J. J Invest Dermatol. 1989; 92 (4): 601-4
• Effects of irradiation on the human immune system. Hoppe RT, Front Radiat Ther Oncol. 1989: 23 140-9
• Expression of T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions. Michie SA, Abel EA, Hoppe RT, Warnke RA, Wood GS. J Invest Dermatol. 1989; 93 (1): 116-20
• Non-Hodgkin lymphoma: influence of lymphography, CT, and bone marrow biopsy on staging and management. Pond GD, Castellino RA, Horning S, Hoppe RT. Radiology. 1989; 170 (1 Pt 1): 159-64
• Outcome of the acute glomerular injury in proliferative lupus nephritis. Chagnac A, Kiberd BA, Fariñas MC, Strober S, Sibley RK, Hoppe R, Myers BD. J Clin Invest. 1989; 84 (3): 922-30
• Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. Leibenhaut MH, Hoppe RT, Efron B, Halpern J, Nelsen T, Rosenberg SA. J Clin Oncol. 1989; 7 (1): 81-91
• Small lymphocytic lymphoma. Morrison WH, Hoppe RT, Weiss LM, Picozzi VJ, Horning SJ. J Clin Oncol. 1989; 7 (5): 598-606
• The management of bulky mediastinal Hodgkin's disease. Hoppe RT, Hematol Oncol Clin North Am. 1989; 3 (2): 265-76
• Benign and malignant forms of erythroderma: cutaneous immunophenotypic characteristics. Abel EA, Lindae ML, Hoppe RT, Wood GS. J Am Acad Dermatol. 1988; 19 (6): 1089-95
• Clinical and immunological studies of cadaveric renal transplant recipients given total-lymphoid irradiation and maintained on low-dose prednisone. Saper V, Chow D, Engleman ED, Hoppe RT, Levin B, Collins G, Strober S. Transplantation. 1988; 45 (3): 540-6
• Combined modality therapy for stage I-II large cell lymphoma. Prestidge BR, Horning SJ, Hoppe RT. Int J Radiat Oncol Biol Phys. 1988; 15 (3): 633-9
• Dissection of the mechanisms of immune injury in rheumatoid arthritis, using total lymphoid irradiation. Gaston JS, Strober S, Solovera JJ, Gandour D, Lane N, Schurman D, Hoppe RT, Chin RC, Eugui EM, Vaughan JH. Arthritis Rheum. 1988; 31 (1): 21-30
• Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials. Hancock SL, Hoppe RT, Horning SJ, Rosenberg SA. Ann Intern Med. 1988; 109 (3): 183-9
• Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. Regula DP, Hoppe RT, Weiss LM. N Engl J Med. 1988; 318 (4): 214-9
• Poikilodermatous mycosis fungoides and atrophic large-plaque parapsoriasis exhibit similar abnormalities of T-cell antigen expression. Lindae ML, Abel EA, Hoppe RT, Wood GS. Arch Dermatol. 1988; 124 (3): 366-72
• T-cell antigen deficiencies and clonal rearrangements of T-cell receptor genes in pagetoid reticulosis (Woringer-Kolopp disease). Wood GS, Weiss LM, Hu CH, Abel EA, Hoppe RT, Warnke RA, Sklar J. N Engl J Med. 1988; 318 (3): 164-7
• The contemporary management of Hodgkin disease. Hoppe RT, Radiology. 1988; 169 (2): 297-304
• Treatment of lupus nephritis with total lymphoid irradiation. Observations during a 12-79-month followup. Strober S, Fariñas MC, Field EH, Solovera JJ, Kiberd BA, Myers BD, Hoppe RT. Arthritis Rheum. 1988; 31 (7): 850-8
• Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease. Horning SJ, Hoppe RT, Hancock SL, Rosenberg SA. J Clin Oncol. 1988; 6 (12): 1822-31
• The non-Hodgkin's lymphomas: pathology, staging, treatment. Hoppe RT, Curr Probl Cancer. 1987 Nov-Dec; 11 (6): 363-447
• Lupus nephritis after total lymphoid irradiation: persistent improvement and reduction of steroid therapy. Strober S, Farinas MC, Field EH, Solovera JJ, Kiberd BA, Myers BD, Hoppe RT. Ann Intern Med. 1987; 107 (5): 689-90
• Mycosis fungoides: management with topical nitrogen mustard. Hoppe RT, Abel EA, Deneau DG, Price NM. J Clin Oncol. 1987; 5 (11): 1796-803
• Solitary plasmacytoma of bone: treatment, progression, and survival. Chak LY, Cox RS, Bostwick DG, Hoppe RT. J Clin Oncol. 1987; 5 (11): 1811-5